Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2021

Open Access 01-12-2021 | Systemic Lupus Erythematosus | Research

Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?

Authors: Yongrui Cai, Zichuan Ding, Xiao Rong, Zong Ke Zhou

Published in: BMC Musculoskeletal Disorders | Issue 1/2021

Login to get access

Abstract

Background

Patients with systemic lupus erythematosus are more likely to receive THA than the general population. However, it is controversial whether SLE increases the risk of complications from THA. The purpose of this retrospective study was to reassess the risks from THA in patients with SLE under the management model of enhanced recovery after surgery.

Methods

Patients with systemic lupus erythematosus diagnosed from December 2011 to December 2017 and treated with THA were compared with THA patients with osteoarthritis. The data were extracted from the medical record system of our department. The chi-square test and t-test were used for comparison.

Results

The postoperative blood loss in patients with SLE was significantly higher than that in the control group, and the postoperative hemoglobin (Hb) and hematocrit (Hct) in the control group were lower than those in the control group (P < 0.05). There was no significant difference in the rate of blood transfusion (9.733 vs 8.133 P = 0.3148) or other complications between the two groups (P > 0.05).

Conclusion

Well-controlled and well-managed SLE will not increase the risk of complications in THA, but can increase the amount of perioperative blood loss. Therefore, perioperative blood management is still essential in SLE patients.
Literature
1.
go back to reference Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. Jama. 1960;174:966–71.CrossRef Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. Jama. 1960;174:966–71.CrossRef
2.
go back to reference Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005. J Rheumatol. 2014;41(5):867–74.CrossRef Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005. J Rheumatol. 2014;41(5):867–74.CrossRef
3.
go back to reference Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, et al. Monitoring of osteonecrosis in systemic lupus Erythematosus: a systematic review and Metaanalysis. J Rheumatol. 2018;45(10):1462–76.CrossRef Hussein S, Suitner M, Béland-Bonenfant S, Baril-Dionne A, Vandermeer B, Santesso N, et al. Monitoring of osteonecrosis in systemic lupus Erythematosus: a systematic review and Metaanalysis. J Rheumatol. 2018;45(10):1462–76.CrossRef
4.
go back to reference Huo MH, Salvati EA, Browne MG, Pellicci PM, Sculco TP, Johanson NA. Primary total hip arthroplasty in systemic lupus erythematosus. J Arthroplast. 1992;7(1):51–6.CrossRef Huo MH, Salvati EA, Browne MG, Pellicci PM, Sculco TP, Johanson NA. Primary total hip arthroplasty in systemic lupus erythematosus. J Arthroplast. 1992;7(1):51–6.CrossRef
5.
go back to reference Tse SM, Mok CC. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus. Lupus. 2017;26(7):715–22.CrossRef Tse SM, Mok CC. Time trend and risk factors of avascular bone necrosis in patients with systemic lupus erythematosus. Lupus. 2017;26(7):715–22.CrossRef
6.
go back to reference Kennedy JW, Khan W. Total hip Arthroplasty in systemic lupus Erythematosus: a systematic review. Int J Rheumatol. 2015;2015:475489.CrossRef Kennedy JW, Khan W. Total hip Arthroplasty in systemic lupus Erythematosus: a systematic review. Int J Rheumatol. 2015;2015:475489.CrossRef
7.
go back to reference Chen DQ, Cancienne JM, Werner BC, Cui Q. Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty? Int Orthop. 2018;42(7):1485–90.CrossRef Chen DQ, Cancienne JM, Werner BC, Cui Q. Is osteonecrosis due to systemic lupus erythematosus associated with increased risk of complications following total hip arthroplasty? Int Orthop. 2018;42(7):1485–90.CrossRef
8.
go back to reference Roberts JE, Mandl LA, Su EP, Mayman DJ, Figgie MP, Fein AW, et al. Patients with systemic lupus erythematosus have increased risk of short-term adverse events after Total hip arthroplasty. J Rheumatol. 2016;43(8):1498–502.CrossRef Roberts JE, Mandl LA, Su EP, Mayman DJ, Figgie MP, Fein AW, et al. Patients with systemic lupus erythematosus have increased risk of short-term adverse events after Total hip arthroplasty. J Rheumatol. 2016;43(8):1498–502.CrossRef
9.
go back to reference Shah UH, Mandl LA, Mertelsmann-Voss C, Lee YY, Alexiades MM, Figgie MP, et al. Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty. Lupus. 2015;24(9):900–8.CrossRef Shah UH, Mandl LA, Mertelsmann-Voss C, Lee YY, Alexiades MM, Figgie MP, et al. Systemic lupus erythematosus is not a risk factor for poor outcomes after total hip and total knee arthroplasty. Lupus. 2015;24(9):900–8.CrossRef
10.
go back to reference Gholson JJ, Wilkinson BG, Brown TS, Gao Y, Dowdle SB, Callaghan JJ. Systemic lupus Erythematosus is a risk factor for complications in Total joint Arthroplasty. Iowa Orthopaedic J. 2018;38:183–90. Gholson JJ, Wilkinson BG, Brown TS, Gao Y, Dowdle SB, Callaghan JJ. Systemic lupus Erythematosus is a risk factor for complications in Total joint Arthroplasty. Iowa Orthopaedic J. 2018;38:183–90.
11.
go back to reference Gu J, Zhang S, Chen L, Feng X, Li H, Feng H, et al. Performing a safe and effective Total hip Arthroplasty on patients with inactive or stably active systemic lupus Erythematosus with osteonecrosis. J Am Acad Orthopaedic Surg. 2020. Gu J, Zhang S, Chen L, Feng X, Li H, Feng H, et al. Performing a safe and effective Total hip Arthroplasty on patients with inactive or stably active systemic lupus Erythematosus with osteonecrosis. J Am Acad Orthopaedic Surg. 2020.
12.
go back to reference Chen CH, Chen TH, Lin YS, Chen DW, Sun CC, Kuo LT, et al. The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study. Arthritis Res Ther. 2020;22(1):214.CrossRef Chen CH, Chen TH, Lin YS, Chen DW, Sun CC, Kuo LT, et al. The impact of systemic lupus erythematosus on the risk of infection after total hip arthroplasty: a nationwide population-based matched cohort study. Arthritis Res Ther. 2020;22(1):214.CrossRef
13.
go back to reference Woo MS, Kang JS, Moon KH. Outcome of total hip arthroplasty for avascular necrosis of the femoral head in systemic lupus erythematosus. J Arthroplast. 2014;29(12):2267–70.CrossRef Woo MS, Kang JS, Moon KH. Outcome of total hip arthroplasty for avascular necrosis of the femoral head in systemic lupus erythematosus. J Arthroplast. 2014;29(12):2267–70.CrossRef
14.
go back to reference Schnaser EA, Browne JA, Padgett DE, Figgie MP, D'Apuzzo MR. Perioperative complications in patients with inflammatory Arthropathy undergoing Total hip Arthroplasty. J Arthroplast. 2016;31(10):2286–90.CrossRef Schnaser EA, Browne JA, Padgett DE, Figgie MP, D'Apuzzo MR. Perioperative complications in patients with inflammatory Arthropathy undergoing Total hip Arthroplasty. J Arthroplast. 2016;31(10):2286–90.CrossRef
15.
go back to reference Dorsch CA, Meyerhoff J. Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus. Arthritis Rheum. 1982;25(8):966–73.CrossRef Dorsch CA, Meyerhoff J. Mechanisms of abnormal platelet aggregation in systemic lupus erythematosus. Arthritis Rheum. 1982;25(8):966–73.CrossRef
16.
go back to reference Shevchuk SV. State of adhesive-aggregative function of platelets in patients with systemic lupus erythematosus. Lik Sprava. 2007;(1–2):27–32. Shevchuk SV. State of adhesive-aggregative function of platelets in patients with systemic lupus erythematosus. Lik Sprava. 2007;(1–2):27–32.
17.
go back to reference Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018;14(4):195–213.CrossRef Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018;14(4):195–213.CrossRef
18.
go back to reference Takahashi H, Moroi M. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus. Am J Hematol. 2001;67(4):262–7.CrossRef Takahashi H, Moroi M. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus. Am J Hematol. 2001;67(4):262–7.CrossRef
19.
go back to reference Merayo-Chalico J, Gónzalez-Contreras M, Ortíz-Hernández R, Alcocer-Varela J, Marcial D, Gómez-Martín D. Total hip Arthroplasty outcomes: an 18-year experience in a single center: is systemic lupus Erythematosus a potential risk factor for adverse outcomes? J Arthroplast. 2017;32(11):3462–7.CrossRef Merayo-Chalico J, Gónzalez-Contreras M, Ortíz-Hernández R, Alcocer-Varela J, Marcial D, Gómez-Martín D. Total hip Arthroplasty outcomes: an 18-year experience in a single center: is systemic lupus Erythematosus a potential risk factor for adverse outcomes? J Arthroplast. 2017;32(11):3462–7.CrossRef
20.
go back to reference Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res. 2014;472(1):66–72.CrossRef Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ. Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res. 2014;472(1):66–72.CrossRef
21.
go back to reference Whiting DR, Duncan CM, Sierra RJ, Smith HM. Tranexamic acid benefits Total joint Arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplast. 2015;30(12):2098–101.CrossRef Whiting DR, Duncan CM, Sierra RJ, Smith HM. Tranexamic acid benefits Total joint Arthroplasty patients regardless of preoperative hemoglobin value. J Arthroplast. 2015;30(12):2098–101.CrossRef
22.
go back to reference Huang ZY, Huang Q, Zeng HJ, Ma J, Shen B, Zhou ZK, et al. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia. BMC Musculoskelet Disord. 2019;20(1):402.CrossRef Huang ZY, Huang Q, Zeng HJ, Ma J, Shen B, Zhou ZK, et al. Tranexamic acid may benefit patients undergoing total hip/knee arthroplasty because of haemophilia. BMC Musculoskelet Disord. 2019;20(1):402.CrossRef
23.
go back to reference Houston BL, Uminski K, Mutter T, Rimmer E, Houston DS, Menard CE, et al. Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk for transfusion: a systematic review and meta-analysis. Transfus Med Rev. 2020;34(1):51–62.CrossRef Houston BL, Uminski K, Mutter T, Rimmer E, Houston DS, Menard CE, et al. Efficacy and safety of tranexamic acid in major non-cardiac surgeries at high risk for transfusion: a systematic review and meta-analysis. Transfus Med Rev. 2020;34(1):51–62.CrossRef
24.
go back to reference Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15(5):528–34.CrossRef Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15(5):528–34.CrossRef
25.
go back to reference Li Z, Du Y, Xiang S, Feng B, Bian Y, Qian W, et al. Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients. Lupus. 2019;28(9):1134–40.CrossRef Li Z, Du Y, Xiang S, Feng B, Bian Y, Qian W, et al. Risk factors of perioperative complications and transfusion following total hip arthroplasty in systemic lupus erythematosus patients. Lupus. 2019;28(9):1134–40.CrossRef
26.
go back to reference Kang Y, Zhang ZJ, Zhao XY, Zhang ZQ, Sheng PY, Liao WM. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients. Eur J Orthop Surg Traumatol. 2013;23(1):73–9.CrossRef Kang Y, Zhang ZJ, Zhao XY, Zhang ZQ, Sheng PY, Liao WM. Total hip arthroplasty for vascular necrosis of the femoral head in patients with systemic lupus erythematosus: a midterm follow-up study of 28 hips in 24 patients. Eur J Orthop Surg Traumatol. 2013;23(1):73–9.CrossRef
27.
go back to reference Hanssen AD, Cabanela ME, Michet CJ Jr. Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am. 1987;69(6):807–14.CrossRef Hanssen AD, Cabanela ME, Michet CJ Jr. Hip arthroplasty in patients with systemic lupus erythematosus. J Bone Joint Surg Am. 1987;69(6):807–14.CrossRef
28.
go back to reference Akita S. Lower extremity wounds in patients with idiopathic thrombocytopenic Purpura and systemic lupus Erythematosus. Int J Low Extrem Wounds. 2015;14(3):224–30.CrossRef Akita S. Lower extremity wounds in patients with idiopathic thrombocytopenic Purpura and systemic lupus Erythematosus. Int J Low Extrem Wounds. 2015;14(3):224–30.CrossRef
29.
go back to reference He Z, Zhou K, Tang K, Quan Z, Liu S, Su B. Perioperative hypoalbuminemia is a risk factor for wound complications following posterior lumbar interbody fusion. J Orthop Surg Res. 2020;15(1):538.CrossRef He Z, Zhou K, Tang K, Quan Z, Liu S, Su B. Perioperative hypoalbuminemia is a risk factor for wound complications following posterior lumbar interbody fusion. J Orthop Surg Res. 2020;15(1):538.CrossRef
Metadata
Title
Does systemic lupus erythematosus increase the risk of complications from total hip arthroplasty?
Authors
Yongrui Cai
Zichuan Ding
Xiao Rong
Zong Ke Zhou
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2021
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-021-04316-3

Other articles of this Issue 1/2021

BMC Musculoskeletal Disorders 1/2021 Go to the issue